As new therapies for HIV infection have been developed, some of the clinical focus related
to AIDS and HIV infection has shifted from acute care, to more chronic issues. Some of these
new clinical issues seem related to the HIV infection itself, while others seem to be side
effects of therapeutic efforts. Metabolic abnormalities, such as dyslipidemia, insulin
resistance, and lipodystrophy (LD) have been observed. The clinical importance of these is
demonstrated by the increased prevalence of cardiovascular disease and diabetes in HIV …